Evidence map›Paper›PMID 31512275›Full record

ArticleJournal of gastroenterology and hepatology2020

Hemorrhoidal disease and chronic venous insufficiency: Concomitance or coincidence; results of the CHORUS study (Chronic venous and HemORrhoidal diseases evalUation and Scientific research).

Philippe Godeberge, Parvez Sheikh, Evgeny Zagriadskiĭ, Varut Lohsiriwat, Abel Jalife Montaño, Pavle Košorok, Heiko De Schepper

Open access · hybridAbstract read
In one paragraph

Article in Journal of gastroenterology and hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Observational
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Symptoms in Dilating Venous Disease.Current cardiology reviews · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 6 countries.

Philippe GodebergeDepartment of Gastroenterology, Mutualist Institute Montsouris, Paris Descartes University, Paris, France.
Parvez SheikhDepartment of Gastroenterology, Saifee Hospital Mumbai, Mumbai, India.
Evgeny ZagriadskiĭDepartment of Proctology, Medical Center 'ON-CLINIC', Moscow, Russia.
Varut LohsiriwatFaculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Abel Jalife MontañoDepartment of Proctology, General Hospital of Mexico, Mexico City, Mexico.
Pavle KošorokDepartment of Proctology, Iatros Medical Centre, Ljubljana, Slovenia.
Heiko De SchepperDepartment of Gastroenterology and Hepatology, University Hospital Antwerp, Edegem, Belgium.
Antwerp University Hospital · BEHospital General de México · MXLjubljana University Medical Centre · SISaifee Hospital · INSiriraj Hospital · THUniversité Paris Cité · FR

Funding

Servier
6 · The paper itself

Abstract

BACKGROUND AND

aimThe CHORUS study (Chronic venous and HemORrhoidal diseases evalUation and Scientific research) was conducted to provide data on patients presenting with hemorrhoidal disease (HD) in clinical practice and to explore the frequency with which it coexists with chronic venous disease (CVD) and shared risk factors.

methodsThis international, noninterventional study enrolled adult patients attending a consultation for hemorrhoidal complaints. The questionnaire completed by physicians established the subjects' demographic and lifestyle characteristics and collected information on HD grade and symptoms and signs of CVD.

resultsA total of 5617 patients were analyzed. Symptoms commonly reported were bleeding (71.8%), pain (67.4%), swelling (55.0%), itching (44.1%), and prolapse (36.2%). Multivariate analysis revealed the variables with the strongest association with HD severity were older age, higher CVD CEAP (Clinical manifestations, Etiologic factors, Anatomic distribution of disease, and underlying Pathophysiology) class, constipation, and male gender (all P < 0.0001). Elevated BMI was a risk factor for HD recurrence. Among women, number of births had a significant association with both HD grade and recurrence. The presence of CVD, reported in approximately half the patients (51.2%), was strongly associated with advanced grade of HD (P < 0.0001). Treatments most commonly prescribed were venoactive drugs (94.3%), dietary fiber (71.4%), topical treatment (70.3%), analgesics (26.3%), and surgery (23.5%).

conclusionsCHORUS provides a snap shot of current profiles, risk factors, and treatments of patients with HD across the globe. The coexistence of HD and CVD in more than half the study population highlights the importance of examining for CVD among patients with a hemorrhoid diagnosis, particularly when shared risk factors are present.

Indexed as

AdolescentAdultAgedBody Mass IndexChronic DiseaseComorbidityConstipationDietary FiberFemaleGravidityHemorrhoidsHumansLife StyleMaleMiddle AgedRisk FactorsDietary FiberVasoconstrictor Agentschronic venous diseasehemorrhoidal diseaserisk factors

Identifiers

PMID31512275
PMCPMC7187474
OpenAlexW2972963231

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.